• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health

    6/2/26 8:05:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email

    LONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering.

    HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial's proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for fuller, healthier-looking hair.

    The enhanced treatment introduces newly engineered Purify™ and Nourish™ treatment tips, designed specifically for the scalp to improve contact, suction, exfoliation, and serum delivery. Together, these advancements help enhance treatment precision, streamline provider experience, and deliver more consistent, visible scalp and hair results.

    "We're seeing a surge in demand for scalp health and hair thinning solutions, with consumers looking for options beyond over-the-counter and invasive treatments," said Whitney Cypes, Chief Brand and Clinical Innovation Officer of SkinHealth Systems. "Our refreshed HydraScalp with Keravive treatment fills that gap, delivering a non-invasive, no-downtime experience that's both comfortable and results-driven. By leveraging the Hydrafacial platform, we're enabling providers to treat the scalp with the same precision and consistency as the skin."

    Consumer interest in scalp health continues to rise, with 73 percent of consumers reporting concerns related to scalp condition and hair growth, and 76 percent of those consumers expressing interest in an in-office treatment to address their concerns¹. As more consumers seek non-invasive options that support scalp health and overall hair appearance, HydraScalp with Keravive offers a zero-downtime treatment designed to help remove buildup and hydrate a dry scalp.

    HydraScalp with Keravive treatment is supported by clinical findings showing²:

    • 75% saw improved hair fullness after 8 weeks, 2 treatments and daily use of take-home peptide complex spray
    • 82% said their hair looked healthier, shinier after 3 treatments over the course of 3 months
    • 6 times more hydrated scalp after one treatment
    • Visible reduction in skin dryness, flaking and roughness after one treatment

    HydraScalp with Keravive treatments follow a three-step protocol: Purify, to remove buildup; Nourish, to hydrate the scalp with peptides and growth factor-inspired ingredients; and Boost, a daily regimen with a take-home peptide complex spray to help maintain results between treatments. HydraScalp with Keravive is available as a single treatment; for optimal results, a series of three treatments is recommended.

    "We're seeing a growing recognition that the scalp is simply an extension of your skin, and it deserves the same level of care," said Board-Certified Dermatologist Dr. Corey Hartman. "Optimal hair health truly begins with optimal scalp health. Factors like lifestyle, environmental exposure, and even the products you use can have a major impact on your scalp health and, in turn, hair growth. Supporting the scalp through consistent cleansing and hydration helps create the right foundation for healthy hair, and treatments like the Hydrafacial HydraScalp with Keravive can help remove buildup, replenish hydration, and promote a balanced scalp environment over time."

    HydraScalp with Keravive is now available at select Hydrafacial providers nationwide. For more information and to find a provider near you, visit hydrafacial.com/find-a-hydrafacialist.

    ¹ NewBeauty Beauty Engine Survey, January 2026 (N=1,464)

    ² Skintuition Report Volume 3 from BeautyHealth, 2025

    ³ HydraScalp MOA Study. Preliminary Findings. Hydrafacial LLC. Data on file. 2026.

    About SkinHealth Systems

    SkinHealth Systems (NASDAQ:SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp® with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.

    Forward-Looking Statements

    Certain statements made in this release are "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995 and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding SkinHealth Systems Inc.'s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words "estimates," "projected," "expects," "anticipates," "forecasts," "plans," "intends," "believes," "seeks," "may," "will," "should," "future," "propose" and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.

    These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside SkinHealth Systems Inc.'s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.

    Important factors that may affect actual results or outcomes include, among others: SkinHealth Systems Inc.'s ability to manage growth; SkinHealth Systems Inc.'s ability to execute its business plan; consumers' perception of scalp health, scalp concerns, and overall hair health trends; the success of HydraScalp with Keravive's launch and how its products are received amongst consumers and providers; potential litigation involving SkinHealth Systems Inc.; changes in applicable laws or regulations; the possibility that SkinHealth Systems Inc. may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties set forth in the sections entitled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (the "SEC") and in the Company's subsequent filings with the SEC such as on a Quarterly Report on Form 10-Q. There may be additional risks that the Company does not presently know of or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. SkinHealth Systems Inc. does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

    Contacts:

    Press: jburchette@devriesglobal.com

    Source: SkinHealth Systems

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/d3ae5707-5ab9-414a-aed9-8c6016bb016e

    https://www.globenewswire.com/NewsRoom/AttachmentNg/9654038d-d66a-45c1-a0fa-340d4fbc35f4



    Get the next $SKIN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    9/19/2025$3.50Buy
    Roth Capital
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/13/24 5:00:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health

    LONG BEACH, Calif., June 02, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced a refresh of its clinically supported Keravive™ scalp treatment as HydraScalp® with Keravive™, marking the next evolution in its scalp health offering. HydraScalp with Keravive is a professional, non-invasive, in-office treatment powered by Hydrafacial's proprietary Vortex-Fusion™ Technology and Keravive biomimetic peptides to deeply cleanse, exfoliate and nourish the scalp. By removing buildup and delivering targeted key ingredients to the scalp, the treatment helps create an optimal scalp environment for

    6/2/26 8:05:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems Reports First Quarter 2026 Financial Results

    LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut

    5/7/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

    LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa

    4/29/26 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on The Beauty Health Company with a new price target

    Roth Capital initiated coverage of The Beauty Health Company with a rating of Buy and set a new price target of $3.50

    9/19/25 8:39:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Jefferies with a new price target

    Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

    11/15/23 7:13:27 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Beattie Edward Scott

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:24:15 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Shridharani Sachin Mahavir

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:19:24 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 3 filed by new insider Tripp Kenneth Robert

    3 - SkinHealth Systems Inc. (0001818093) (Issuer)

    4/22/26 4:15:55 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    SEC Filings

    View All

    Amendment: SkinHealth Systems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K/A - SkinHealth Systems Inc. (0001818093) (Filer)

    5/21/26 4:40:52 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    8-K - SkinHealth Systems Inc. (0001818093) (Filer)

    5/12/26 4:08:38 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by SkinHealth Systems Inc.

    10-Q - SkinHealth Systems Inc. (0001818093) (Filer)

    5/7/26 5:16:36 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    View All

    SkinHealth Systems Inc. Appoints Three New Independent Directors to Board

    LONG BEACH, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced the appointment of three new independent directors to its Board of Directors (the "Board"): Mr. Kenneth Tripp, Dr. Sachin Shridharani, and Mr. E. Scott Beattie, each effective as of April 17, 2026. "These three appointments reflect exactly the kind of Board we are building at SkinHealth Systems – one that brings extensive operational expertise in medtech, deep clinical authority in aesthetics, and proven leadership in scaling iconic global consumer brands," said Brent Saunders, Chairman of SkinHealth Systems

    4/22/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors

    LONG BEACH, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- The BeautyHealth Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of global aesthetics leader, Philippe Schaison, PharmaD, to its Board of Directors, effective as of October 30, 2025. Dr. Schaison has spent over 20 years leading organizations across the global aesthetics, biotech, and consumer health industries. He currently serves as Chief Executive Officer and a director of Soltégo, Inc., a bio-cosmetic company. Previously, Dr. Schaison was Chief Executive Officer NA of Syneron Candela, President of Allergan Aesthetics, and held senior leadership roles at Clarins, Johnson & Johnson, and L'Oré

    11/3/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Financials

    Live finance-specific insights

    View All

    SkinHealth Systems Reports First Quarter 2026 Financial Results

    LONG BEACH, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ:SKIN) ("SkinHealth Systems" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2026 ("Q1 2026"). "First quarter results reflect the strength of the business. We delivered revenue within our guidance range, significantly outperformed on adjusted EBITDA, and continued to expand margins through disciplined execution. "While the market remains challenging and we are lowering our full-year revenue outlook, the fundamentals are intact. The installed base is growing, the brand is strong, and we are taking direct action to improve execut

    5/7/26 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026

    LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. ((formerly The Beauty Health Company, NASDAQ:SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 financial results after market close on Thursday, May 7, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the investor relations section of the Company's website at www.skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure Informa

    4/29/26 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results

    LONG BEACH, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the full year and fourth quarter ended December 31, 2025 ("Q4 2025"). "Our fourth quarter results reflects meaningful structural progress in margins, profitability, and balance sheet strength as our operational improvements are beginning to take hold," said Pedro Malha, President and CEO of BeautyHealth. "BeautyHealth enters 2026 with a strong foundation — a globally recognized brand, one of the largest installed bases in aesthetics, and a strong recurring consumables model. Our focus no

    3/12/26 4:01:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care